ArticleBMJ open2025

LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiforme.

Johannes Pärtel Truusalu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.